Literature DB >> 29742925

Widowed status increases the risk of death in vulvar cancer.

San-Gang Wu1, Qing-Jiang Lin2, Feng-Yan Li3, Jia-Yuan Sun3, Zhen-Yu He3, Juan Zhou4.   

Abstract

AIM: To evaluate the effect of marital status on survival of patients with vulvar cancer. MATERIALS &
METHODS: A total of 4001 patients with vulvar cancer were included from the SEER database. Statistical analyses were performed using χ2 test, Kaplan-Meier method, Cox regression proportional hazards and a 1:1 propensity score-matching.
RESULTS: The 8-year vulvar cancer-related survival in married, divorced, single and widowed patients were 78.6, 82.2, 78.9 and 61.6%, respectively (p < 0.001). In multivariate analysis, widows patients had significantly worse vulvar cancer survival than the nonwidowed counterparts in unmatched and matched populations.
CONCLUSION: Being widowed is associated with greater risk of vulvar cancer mortality than the nonwidowed counterparts.

Entities:  

Keywords:  SEER; marital status; propensity score matching; survival; vulvar cancer; widowhood

Mesh:

Year:  2018        PMID: 29742925     DOI: 10.2217/fon-2018-0255

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

1.  A prognostic nomogram based on lymph node ratio for postoperative vulvar squamous cell carcinoma from the Surveillance, Epidemiology, and End Results database: a retrospective cohort study.

Authors:  Lei Lei; Liao Tan; Xingping Zhao; Fei Zeng; Dabao Xu
Journal:  Ann Transl Med       Date:  2020-11

2.  Widowed status predicts poor overall survival of Chinese patients with prostate cancer.

Authors:  Si-Huai Huang; Yi-Ning Li; Jian-Wei Li; Yi-Hong Guo; Xue-Feng Su
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

3.  Survival and prognostic factors in primary vaginal cancer: an analysis of 2004-2014 SEER data.

Authors:  Jianqin Huang; Meiyu Cai; Zhiling Zhu
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.